Insurance Brokers

Health In Tech

shopify

Conference Minutes

OpenAI

GOOG

GOOGL

SHOP

GGLS

GGLL

FIGS

Below is Dolphin Research's Trans of the FY25 Q4 earnings call for $Shopify (SHOP.US). For the earnings breakdown, see 'Shopify: Solid results yet a plunge — are commerce agents a silver bullet or a poison?'.Core metrics recap, and regional/channel performance are as follows. North America revenue rose 28% YoY, with the platform now covering over 14% of the US e-com market.International revenue grew 36% YoY. Nearly half of merchants are outside North America, and Europe Q4 GMV increased 45% (FXN +35%). Offline: GMV was up 29% YoY...

Alphabet - C

Alphabet

Shopify 

Paymentus

Direxion Daily Googl Bear 1x Shares

Direxion Daily GOOGL Bull 2X Shares

Figs

SHOP (Trans): Under the e-com Agent model, the company still monetizes primarily through payments

Health In Tech released FY2026 Q1 earnings on May 13 After-Market EST, actual revenue USD 8.772 M (forecast USD 7.464 M), actual EPS USD -0.03 (forecast USD -0.02)

Health In Tech to release FY2026 Q1 earnings on May 13 After-Market EST, forecast revenue USD 7.464 M, EPS USD -0.02

Health In Tech released FY2025 earnings on March 25 After-Market EST, actual revenue USD 33.33 M (forecast USD 32.37 M), actual EPS USD 0.02 (forecast USD 0.015)

Health In Tech released FY2025 Q4 earnings on March 25 After-Market EST, actual revenue USD 7.509 M (forecast USD 7.273 M), actual EPS USD -0.01 (forecast USD -0.01)

Health In Tech Completes $7 Million Private Placement Financing

Health In Tech to Release FY2025 Q4 Earnings on March 25, 2026 After-Market EST, Forecast Revenue USD 7.273M, EPS USD -0.01

Health In Tech released FY2025 9 Months earnings on November 12 After-Market (EST), actual revenue USD 25.82 M, actual EPS USD 0.0271

Health In Tech released FY2025 Q3 earnings on November 12 After-Market (EST), actual revenue USD 8.49 M (forecast USD 7.05 M), actual EPS USD 0.008 (forecast USD 0.01)

Health In Tech to release FY2025 Q3 earnings on November 3 After-Market EST, forecast revenue USD 7.271 M, EPS USD 0.005

Health In Tech released FY2025 Q2 earnings on July 21 After-Market EST, actual revenue USD 9.314 M (forecast USD 7.47 M), actual EPS USD 0.01 (forecast USD 0.005)

Health In Tech released FY2025 Semi-Annual earnings on July 21 After-Market EST, actual revenue USD 17.33 M, actual EPS USD 0.0199

Health In Tech to Release FY2025 Q2 Earnings on July 21 After-Market EST, Forecast Revenue USD 7.47 M, EPS USD 0.005

Earnings report released on April 14, 2025 (BJT) with actual revenue of USD 8.015 M and actual EPS of USD 0.0091

Health In Tech to Release FY2025 Q1 Earnings on April 14 After-Market EST, Forecast Revenue USD 6.869 M, EPS USD 0.02

Health In Tech released FY2023 Q4 earnings on March 17, 2025 (EST), with actual revenue of 5.216 M USD and EPS of 0.0148 USD

Health In Tech released FY2024 annual earnings on March 17 After-Market EST, with actual revenue of 19.49 M USD and EPS of 0.01 USD

Health In Tech released FY2024 Q4 earnings on March 17 After-Market (EST), actual revenue 4.905 M USD, actual EPS -0.0084 USD

Health In Tech to Release FY2024 Q4 Earnings on March 17, 2025, After-Market EST

HIT.US released FY2024 Q3 earnings on November 6 (BJT) with actual revenue of 4.459 MUSD and EPS of 0.0072 USD

HIT.US released FY2023 9 Months Earnings on November 6, 2024 (BJT) with actual revenue of 13.94 MUSD and EPS of 0.0288 USD

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

Earnings Watch

Health In Tech | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 8.772 M

Health In Tech shares are trading lower after the company reported worse-than-expected Q1 sales results.

benzinga_article

Health In Tech (NASDAQ:HIT) reported Q1 2026 revenue growth of 9% to $8.8 million, but a wider net loss of $1.6 million. The company is increasing investments in sales and technology to capture a larger share of the self-funded health insurance market, where adoption is higher among large businesses. CFO Julia Qian noted total operating expenses rose to $6.7 million, reflecting a strategic shift towards growth initiatives. Health In Tech reiterated its full-year revenue guidance of $45 million to $50 million, indicating potential year-over-year growth of 35% to 50%.

Market Beat

Health In Tech Q1 Earnings Call Highlights

Health In Tech, Inc. (HIT) presented an AI-driven platform aimed at helping small and medium-sized businesses adopt self-funded health plans more easily. The company emphasizes its scalable, fee-based model in a large market, highlighting tools like eDIYBS software for faster quoting and a nationwide provider network. HIT bears no underwriting risk and has received a Buy rating with a $4.00 price target. However, Spark's AI Analyst rates HIT as Neutral due to solid financial health but weak technicals and high P/E valuation. Current market cap stands at $86.76M.

Tip Ranks

Health In Tech Showcases AI Platform in Investor Presentation

Health In Tech | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 8.772 M

XTNT

Xtant Medical Reports First Quarter 2026 Financial Results | XTNT Stock News

StockTitan

Xtant Med

Xtant Medical Reports First Quarter 2026 Financial Results | XTNT Stock News

Health In Tech(HIT.US)

Health In Tech | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 8.772 M

Health In Tech shares are trading lower after the company reported worse-than-expected Q1 sales results.

Health In Tech Q1 Earnings Call Highlights

Health In Tech Showcases AI Platform in Investor Presentation

Health In Tech | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 8.772 M

Xtant Medical Reports First Quarter 2026 Financial Results | XTNT Stock News